CORONARY STENTS MARKET ANALYSIS

Coronary Stents Market, By Product Type (Bare-metal Stents, Drug Eluting Stents, and Bioabsorbable Stents), By Material (Metallic (Stainless Steel, Silicon Carbide, Titanium Nitride Oxide, Cobalt Chromium, Platinum Chromium, and Others) and Polymeric (Non-degradable/Permanent Stents and Degradable/Temporary Stents)), By End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Feb 2023
Code : CMI2031
Pages :198
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Coronary Stents Market: Key Developments

On 8 February 2023, DSM, a purpose-led global science-based company, announced its partnership with Svelte, a privately held company, focused on delivering novel products in the coronary stents market to develop DISCREET bioresorbable coating technology used with SLENDER IDS and DIRECT RX drug eluting systems (DES)

In July 2021, Abbott, one of the leading multinational pharmaceutical companies in India, stated that its product Xience Skypoint has received U.S. Food and Drug Administration (FDA) approval the Conformité Européene (CE) mark which is the European Union's (EU) mandatory conformity marking for regulating the goods sold within the European region, and Japanese Pharmaceuticals and Medical Devices Agency (PMDA) approval in Japan for the broadest expansion with the availability of extended sizes of 4.5 mm and 5 mm offerings.

On 15 June 2020, iVascular, advanced medical devices manufacturer, announced the global launch of essential pro, a novel reliable Drug Coated Balloon (DCB), essential pro is indicated for the dilatation of stenosis or coronary artery or bypass grafts occlusions, including small vessels, as well as for residual stenosis after treatment with balloon or endoprosthesis and pre-and post-dilation of coronary endovascular prosthesis.

On 31 May 2021, Alvimedica, a manufacturer of coronary stents, balloon catheters, diagnostic and guiding catheters announced the launch of its new product, NiTiDES, a highly innovative self-expanding drug eluting stent (DES) eluting a Sirolimus based formulation named Amphilimus.